In April 2019, Montpellier CHU hospital acquired an innovative neuroradiology machine to treat serious cerebrovascular accidents more rapidly and effectively. This cutting-edge tool paves the way for other innovations.
A flagship project for Montpellier France Health HubThe Azurion platform is also connected with digital simulation software. These applications analyze the size and position of implants in the brain in real-time (stents, aneurysm “cages”), thus helping to improve procedure safety.
The extremely innovative equipment will also be used for research and teaching purposes, both of which are strengths of the Montpellier health facility. A European and global reference for treating vascular cerebral pathologies, performing over 400 cerebral thrombectomies and treating 400 aneurysms annually, the CHU university hospital further reinforces its position as a leader, with support from Montpellier Métropole.
Innovation in neuroradiology is one of the focuses of the Montpellier France Health Hub initiative, a project led by Montpellier Méditerranée Métropole to develop an excellence sector that unites local hospitals, research centers, and companies. The initiative leverages the Metropolitan Innovation Pact, which enables Montpellier Métropole and the French government to co-fund part of the investment in this project, for an amount totaling 2.6 million euros.
The CHU will be able to use this cutting-edge tool to develop other therapeutic innovations, such as making it easier to detect deep epileptic foci.